(NaturalNews) The Center for Public Integrity is a public interest investigative journalism organization. This group has recently obtained copies of a Centers for Disease Control and Prevention (CDC) study of environmental and health data in eight states that was scheduled to be published in July 2007. The report revealed elevated rates of lung, colon, and breast cancer; low birth weight; and infant mortality in several geographical areas. It has not yet been published.
A few days before the study was to be released it was pulled. In addition, at the same time its lead author, Christopher De Rosa, was removed from the position he held since 1992. The Center for Public Integrity wants to know why. Read more..
http://www.naturalnews.com/023116.html
Showing posts with label CDC. Show all posts
Showing posts with label CDC. Show all posts
2.29.2008
Mercks New ProQuad Vaccine Linked To More Convulsions
ATLANTA - Children suffered higher rates of fever-related convulsions when they got a Merck & Co. combination vaccine instead of two separate shots, according to a new study presented Wednesday.
The results prompted a federal advisory panel on vaccines to water down their preference for the combo vaccine ProQuad, which protects against measles, mumps and rubella as well as chickenpox. Read more..
http://www.startribune.com/lifestyle/health/16054722.html
ONCE AGAIN..FOLLOW THE MONEY. VACCINATE YOUR CHILD AND WORRY ABOUT THE SIDE AFFECTS LATER. WOULD YOU EAT OR FEED YOUR CHILD SOMETHING FROM AN UNMARKED PACKAGE WITHOUT KNOWING WHATS INSIDE?
THEN WHY WOULD YOU CONTINUOUSLY LET SOMEONE EXPERIMENT ON THEM BY POKING THEM WITH NEEDLES AND INJECTING THEM WITH A FOREIGN SUBSTANCE THAT YOU DON'T EVEN KNOW WHAT IT CONTAINS?
The results prompted a federal advisory panel on vaccines to water down their preference for the combo vaccine ProQuad, which protects against measles, mumps and rubella as well as chickenpox. Read more..
http://www.startribune.com/lifestyle/health/16054722.html
ONCE AGAIN..FOLLOW THE MONEY. VACCINATE YOUR CHILD AND WORRY ABOUT THE SIDE AFFECTS LATER. WOULD YOU EAT OR FEED YOUR CHILD SOMETHING FROM AN UNMARKED PACKAGE WITHOUT KNOWING WHATS INSIDE?
THEN WHY WOULD YOU CONTINUOUSLY LET SOMEONE EXPERIMENT ON THEM BY POKING THEM WITH NEEDLES AND INJECTING THEM WITH A FOREIGN SUBSTANCE THAT YOU DON'T EVEN KNOW WHAT IT CONTAINS?
All Kids Must Get Flu Vaccine, Panel Says To CDC
All U.S. children aged from six months up to 18 should be immunized every year against influenza, a panel of federal vaccine advisers said on Wednesday.
The panel, which advises the U.S. Centers for Disease Control and Prevention on vaccine matters, agreed unanimously at its regular meeting in Atlanta that the new recommendations should go into effect as soon as possible, but no later than the 2009-2010 flu season.
The vote from the Advisory Committee on Immunization Practices would add about 30 million children to the list of those who should be vaccinated, CDC spokesman Curtis Allen said. The current recommendations cover children aged 6 months to 5 years old.
Read more..
http://news.aol.com/health/story/_a/all-kids-must-get-flu-vaccine-panel-says/20080227152609990001?ncid=NWS00010000000001
EVIDENTLY, THEY DID NOT MAKE ENOUGH MONEY FROM THEIR VACCINATIONS THAT WERE INEFFECTIVE? LET'S SEE...THEY WON'T DISCLOSE CURES FOR CANCER AND THE MANY OTHER DIS-EASES THAT HAVE BEEN AROUND FOREVER, THEY SPEND TAX MONEY ON CLONING AND REPLICATING HUMAN ORGANS..AND NOW, THEY'RE COMING UP WITH A VACCINE FOR EVERYTHING. I WOULD NOT PUT THAT AMOOUNT OF UNKNOWN BACTERIA AND LIVING VIRUSES INTO A PET MUCH LESS A CHILD.
The panel, which advises the U.S. Centers for Disease Control and Prevention on vaccine matters, agreed unanimously at its regular meeting in Atlanta that the new recommendations should go into effect as soon as possible, but no later than the 2009-2010 flu season.
The vote from the Advisory Committee on Immunization Practices would add about 30 million children to the list of those who should be vaccinated, CDC spokesman Curtis Allen said. The current recommendations cover children aged 6 months to 5 years old.
Read more..
http://news.aol.com/health/story/_a/all-kids-must-get-flu-vaccine-panel-says/20080227152609990001?ncid=NWS00010000000001
EVIDENTLY, THEY DID NOT MAKE ENOUGH MONEY FROM THEIR VACCINATIONS THAT WERE INEFFECTIVE? LET'S SEE...THEY WON'T DISCLOSE CURES FOR CANCER AND THE MANY OTHER DIS-EASES THAT HAVE BEEN AROUND FOREVER, THEY SPEND TAX MONEY ON CLONING AND REPLICATING HUMAN ORGANS..AND NOW, THEY'RE COMING UP WITH A VACCINE FOR EVERYTHING. I WOULD NOT PUT THAT AMOOUNT OF UNKNOWN BACTERIA AND LIVING VIRUSES INTO A PET MUCH LESS A CHILD.
1.18.2008
Merck's Cervical Cancer Vaccine, Gardasil®, Added To The Cdc Vaccines For Children Contract
Merck & Co., Inc. today announced that the U.S. Centers for Disease Control and Prevention (CDC) has added Merck's cervical cancer vaccine, GARDASIL® [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] to the CDC's Vaccines for Children (VFC) contract for girls and women aged 9 to 18. GARDASIL was approved on June 8 by the Food and Drug Administration (FDA) for use in girls and women ages 9 to 26 years. GARDASIL is the world's first and only vaccine available for the prevention of HPV types 16- and 18-related cervical cancer, cervical pre-cancers (CIN 2/3 and AIS), vulvar pre-cancers (VIN 2/3) and vaginal pre-cancers (VaIN 2/3) and for the prevention of genital warts and low-grade cervical lesions (CIN 1) caused by HPV types 6, 11, 16 and 18.
"The addition of GARDASIL to the VFC program is a very positive step towards protecting the future health of girls and young women in this country against cervical cancer caused by HPV types 16 and 18," said Mark Feinberg, M.D., Ph.D., vice president, Policy, Public Health and Medical Affairs in the Merck Vaccine Division. "Inclusion of GARDASIL in the VFC program, coupled with private insurance coverage and Merck's Vaccine Patient Assistance Program, represent important means to facilitate broad and equitable access to GARDASIL."
Health insurers covering approximately 94 percent of privately insured lives in the US (currently more than 95 insurance plans) have decided to reimburse GARDASIL. Many lives not covered by Managed Care will now be covered under the VFC Program. Merck has also initiated a new patient assistance program for vaccines. Through this new program, currently available in private physicians' offices, Merck is making available, free of charge, GARDASIL and other Merck vaccines indicated for use in individuals aged 19 and older who are uninsured and who are unable to afford vaccines.
Since 1994, the VFC program has provided vaccines to children through age 18 who are Medicaid-eligible, uninsured, underinsured or Native American. After the CDC's Advisory Committee for Immunization Practices (ACIP) has made a recommendation for the use of a given vaccine, the ACIP votes on whether the vaccine should be included in the VFC program. At the June 2006 meeting of the ACIP, the committee voted unanimously to recommend GARDASIL to the VFC program. Eligible adolescents may receive recommended vaccines through VFC once the CDC contracts for the purchase of the vaccine, a process that is now complete. Read more..
http://www.medicalnewstoday.com/articles/55737.php
"The addition of GARDASIL to the VFC program is a very positive step towards protecting the future health of girls and young women in this country against cervical cancer caused by HPV types 16 and 18," said Mark Feinberg, M.D., Ph.D., vice president, Policy, Public Health and Medical Affairs in the Merck Vaccine Division. "Inclusion of GARDASIL in the VFC program, coupled with private insurance coverage and Merck's Vaccine Patient Assistance Program, represent important means to facilitate broad and equitable access to GARDASIL."
Health insurers covering approximately 94 percent of privately insured lives in the US (currently more than 95 insurance plans) have decided to reimburse GARDASIL. Many lives not covered by Managed Care will now be covered under the VFC Program. Merck has also initiated a new patient assistance program for vaccines. Through this new program, currently available in private physicians' offices, Merck is making available, free of charge, GARDASIL and other Merck vaccines indicated for use in individuals aged 19 and older who are uninsured and who are unable to afford vaccines.
Since 1994, the VFC program has provided vaccines to children through age 18 who are Medicaid-eligible, uninsured, underinsured or Native American. After the CDC's Advisory Committee for Immunization Practices (ACIP) has made a recommendation for the use of a given vaccine, the ACIP votes on whether the vaccine should be included in the VFC program. At the June 2006 meeting of the ACIP, the committee voted unanimously to recommend GARDASIL to the VFC program. Eligible adolescents may receive recommended vaccines through VFC once the CDC contracts for the purchase of the vaccine, a process that is now complete. Read more..
http://www.medicalnewstoday.com/articles/55737.php
CDC Purchasing 10 Million Doses of Gardasil
The Centers for Disease Control and Prevention’s (CDC) latest round of acquisitions under its Vaccines for Children program includes the purchase of 10 million doses of Merck’s human papillomavirus (HPV) vaccine Gardasil, according to CDC solicitation documents.
The agency’s planned purchase is the same as its 2007 procurement.
Merck is the only FDA-approved manufacturer of quadrivalent HPV, which is called for in the procurement specifications. Gardasil (HPV quadrivalent [types 6, 11, 16 and 18] vaccine, recombinant) protects against four different strains of the virus, unlike GlaxoSmithKline’s (GSK) Cervarix (HPV, AS04 adjuvant-adsorbed).
Cervarix, approved in Europe, provides 100 percent protection against strains 16 and 18 only, according to the company. Although GSK has indicated that the product provides broader protection against cancer-causing HPV strains, the firm’s marketing authorization from the European Medicines Agency only references strains 16 and 18.
The FDA recently issued a complete response letter for Cervarix, requesting more information about the product. Results from a head-to-head trial comparing Cervarix with Gardasil could be available later this year.
The anticipated performance period of the contract starts April 1 and continues through March 31, 2009. Only measles, mumps and rubella and Hib vaccines are subject to statutory price ceilings. Bids close Jan. 28. The solicitation can be accessed at fs1.fbo.gov/EPSData/HHS/Synopses/2965/2008-N-19196/VFC2008Solicitation.doc.
http://www.fdanews.com/newsletter/article?artueId=11210icleId=103084&iss
The agency’s planned purchase is the same as its 2007 procurement.
Merck is the only FDA-approved manufacturer of quadrivalent HPV, which is called for in the procurement specifications. Gardasil (HPV quadrivalent [types 6, 11, 16 and 18] vaccine, recombinant) protects against four different strains of the virus, unlike GlaxoSmithKline’s (GSK) Cervarix (HPV, AS04 adjuvant-adsorbed).
Cervarix, approved in Europe, provides 100 percent protection against strains 16 and 18 only, according to the company. Although GSK has indicated that the product provides broader protection against cancer-causing HPV strains, the firm’s marketing authorization from the European Medicines Agency only references strains 16 and 18.
The FDA recently issued a complete response letter for Cervarix, requesting more information about the product. Results from a head-to-head trial comparing Cervarix with Gardasil could be available later this year.
The anticipated performance period of the contract starts April 1 and continues through March 31, 2009. Only measles, mumps and rubella and Hib vaccines are subject to statutory price ceilings. Bids close Jan. 28. The solicitation can be accessed at fs1.fbo.gov/EPSData/HHS/Synopses/2965/2008-N-19196/VFC2008Solicitation.doc.
http://www.fdanews.com/newsletter/article?artueId=11210icleId=103084&iss
1.03.2008
Gardasil Causing Pain and Fainting?
Health officials have touted the Gardasil vaccine as an important new protection against a cancer-causing sexually transmitted virus. In recent months, they've also noted reports of pain and fainting from the shot.
During its first year of use, reports of girls fainting from vaccinations climbed, but it's not clear whether the pain of the cervical cancer vaccine was the reason for the reaction.
Officials at Merck & Co., which makes the vaccine, acknowledge the sting. They attribute it partly to the virus-like particles in the shot. Pre-marketing studies showed more reports of pain from Gardasil than from dummy shots, and patients reported more pain when given shots with more of the particles.
Meanwhile, U.S. health officials have noticed a rise in reports of vaccine-associated fainting in girls. From 2002-2004 there were about 50 reports of fainting; from 2005 until last July, there were about 230. About 180 of those cases followed a shot of Gardasil, which came on the market in 2006.
But it's not clear that Gardasil's sting is related to the fainting increase, said Dr. Barbara Slade, an immunization safety specialist at the U.S. Centers for Disease Control and Prevention.
http://news.yahoo.com/s/ap/20080103/ap_on_he_me/painful_shot
During its first year of use, reports of girls fainting from vaccinations climbed, but it's not clear whether the pain of the cervical cancer vaccine was the reason for the reaction.
Officials at Merck & Co., which makes the vaccine, acknowledge the sting. They attribute it partly to the virus-like particles in the shot. Pre-marketing studies showed more reports of pain from Gardasil than from dummy shots, and patients reported more pain when given shots with more of the particles.
Meanwhile, U.S. health officials have noticed a rise in reports of vaccine-associated fainting in girls. From 2002-2004 there were about 50 reports of fainting; from 2005 until last July, there were about 230. About 180 of those cases followed a shot of Gardasil, which came on the market in 2006.
But it's not clear that Gardasil's sting is related to the fainting increase, said Dr. Barbara Slade, an immunization safety specialist at the U.S. Centers for Disease Control and Prevention.
http://news.yahoo.com/s/ap/20080103/ap_on_he_me/painful_shot
12.28.2007
Studies Fail to Demonstrate Safety or Effectiveness of Influenza Vaccine in Children and Adults
An independent analysis by the internationally renowned Cochrane Collaboration of worldwide influenza vaccine studies, published in the British Medical Journal on Oct. 28, concluded there is little scientific proof that inactivated influenza vaccine is safe and effective for children and adults. Citing the Cochrane Collaboration finding as well as methodological flaws in a child influenza vaccine study published Oct. 25 in the Journal of the American Medical Association (JAMA), the National Vaccine Information Center is calling on the Centers for Disease Control (CDC) to stop recommending annual flu shots for all infants and children until methodologically sound studies are conducted.
http://www.nvic.org/PressReleases/pr1031flu.htm
http://www.nvic.org/PressReleases/pr1031flu.htm
Subscribe to:
Posts (Atom)
